Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Megestrol Acetate for Malnourished First-Line NSCLC
NCT07477808Phase 3Not yet recruiting
- Sponsor
- Hunan Cancer Hospital
- Start
- Apr 2026
- Primary completion
- Apr 2028
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial of megestrol in Malnutrition (2 arms), sponsored by Hunan Cancer Hospital. Primary endpoint: Change in body weight at 12 weeks. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
megestrol
03
Conditions
Malnutrition
Beyond the preview
Go deeper on NCT07477808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07477808.